Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2007 | 12-2006 | |
| Operating Expenses | 241 | 0 |
| Operating Income | -241 | N/A |
| Other Income | -30 | 0 |
| Pre-tax Income | -271 | 0 |
| Net Income Continuous | -271 | N/A |
| Net Income | $-271 | $N/A |
| EPS Basic Total Ops | -0.04 | N/A |
| EPS Basic Continuous Ops | -0.04 | N/A |
| EPS Diluted Total Ops | -0.04 | N/A |
| EPS Diluted Continuous Ops | -0.04 | N/A |
| EBITDA(a) | $-241 | $N/A |